Trump signs COVID-19 relief bill, calls on Congress to remove 'wasteful items'


President Trump on Sunday signed into law the $900 billion COVID-19 relief bill and $1.4 trillion omnibus spending legislation that were packaged together and passed with bipartisan, bicameral support in Congress last week.
It was unclear whether Trump would sign the package before a looming government shutdown on Tuesday. He had expressed his displeasure with the relief bill primarily because it included just $600 stimulus checks rather than the $2,000 he preferred, but he had also complained about elements of the spending bill like foreign aid. In his statement announcing the signing, Trump called for Congress to remove what he described as "wasteful items." He added that the House will vote on $2,000 checks Monday, while the Senate will begin the process of setting up a vote on the issue.
The president's opposition appeared to blindside lawmakers on both sides of the aisle, as well his own negotiating team led by Treasury Secretary Steven Mnuchin, and it looked like he might veto the bill, or simply sit on it, but after reportedly changing his mind repeatedly over the last few days he relented.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Democratic and some Republican lawmakers agreed the direct payments should be heftier, but many still criticized Trump for holding off, since it put other measures like enhanced unemployment benefits and eviction moratoriums in jeopardy. Sen. Bernie Sanders (I-Vt.), for example, said Sunday that Trump should quickly approve the bill and let Congress work on increasing the individual payments separately this week. Read more at The Associated Press and The Washington Post.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Scientists want to fight malaria by poisoning mosquitoes with human blood
Under the radar Drugging the bugs
By Devika Rao, The Week US Published
-
Crossword: March 31, 2025
The Week's daily crossword
By The Week Staff Published
-
Sudoku medium: March 31, 2025
The Week's daily medium sudoku puzzle
By The Week Staff Published
-
Measles outbreak spreads, as does RFK Jr.'s influence
Speed Read The outbreak centered in Texas has grown to at least three states and Health Secretary Robert F. Kennedy Jr. is promoting unproven treatments
By Peter Weber, The Week US Published
-
RFK Jr. offers alternative remedies as measles spreads
Speed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows
By Peter Weber, The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published